UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 Or Delaware 27-3865930 (State or other jurisdic ...

文章核心观点 - 文章认为HCA Healthcare是一家具有强劲增长潜力的公司 其结合了优异的增长评分和高评级 是增长投资者的理想选择 [2][9] 增长投资策略 - 增长投资者关注财务增长高于平均水平的股票 但此类股票通常伴随较高风险和波动性 [1] - 研究表明 具备最佳增长特征的股票持续跑赢市场 结合A或B级增长评分和Zacks 1或2级评级的股票回报更佳 [3] HCA Healthcare增长驱动因素 - 公司历史每股收益增长率为15[%] 但预计今年每股收益将增长20[%] 远超行业平均的17[%]增长预期 [4] - 公司资产利用率较高 销售与总资产比率为1[.]25 即每1美元资产产生1[.]25美元销售额 显著高于行业平均的0[.]71 [5] - 公司预计今年销售额将增长6[%] 而行业平均增长预期为0[%] [6] - 公司当前年度盈利预测呈上调趋势 Zacks共识预期在过去一个月内大幅上升2[%] [7]

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is HCA Healthcare (HCA) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.HCA Healthcare is a member of the Medical sector. This group includes 955 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual st ...

Shares of HCA Healthcare (HCA) have been strong performers lately, with the stock up 11.2% over the past month. The stock hit a new 52-week high of $469.18 in the previous session. HCA has gained 55.9% since the start of the year compared to the 2.6% move for the Zacks Medical sector and the 7% return for the Zacks Medical Services industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last fo ...

公司概况与市场地位 - 公司是医疗保健行业的领先实体，以其庞大的医院网络和对提供优质医疗服务的奉献而闻名 [1] - 公司与Tenet Healthcare和Community Health Systems等巨头竞争，并以其质量和覆盖范围脱颖而出 [1] - 公司拥有约1046亿美元的市场估值，凸显了其在行业中的重要地位 [5] 股价表现与交易动态 - 公司股价近期上涨1.56%或6.88美元，达到447.04美元 [3] - 当日交易出现显著波动，股价在424.21美元的低点和461.56美元的高点之间波动，其中高点为过去一年最高价 [3] - 公司过去一年最低股价为289.98美元 [3] - 当日交易量达到2,847,054股，显示出强劲的投资者参与度 [5] 机构评级与财务举措 - 巴克莱银行维持对公司股票的“增持”评级，并将其目标价从445美元上调至494美元，显示出对公司增长前景的乐观看法 [2] - 公司通过子公司HCA Inc宣布公开发行高级票据，所筹资金将用于一般公司用途，重点是偿还现有债务 [4] - 票据的具体条款将根据市场条件最终确定 [4]

HCA Healthcare Inc. (NYSE:HCA) posted upbeat third-quarter 2025 financial results on Friday.HCA reported total revenues of $19.16 billion, representing a 9.6% year-over-year increase, surpassing the consensus estimate of $18.57 billion. The hospital chain reported adjusted earnings of $6.96, up from $4.90 a year ago, surpassing the consensus of $5.72.“Our teams continued to execute our agenda at a high level, and we remain disciplined in our efforts to improve care for our patients by increasing access, inv ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowing. ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: HCA Healthcare raised its full-year profit and revenue outlook on Friday after newly approved state supplemental payment programs in the third quarter helped boost the for-profit’s revenues past Wall Street expectations. The operator now expects revenue between $75 billion and $76.5 billion, and net income between $6.5 billion and $6.72 billion ...

Because of the fluid nature of the federal policy environment, we will limit our early thoughts for 2026 to our views on demand and the cost environment. We continue to see solid demand across our markets for health care and believe volumes will be within our long-term 2% to 3% growth range. As it pertains to operating costs, we expect mostly stable trends consistent with the past couple of years. As usual, there are some pressures in certain areas, but we believe our resiliency plan should provide some rel ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...